A Brief Overview of the ...
The newly revised Examination Guidelines (2023 version) (hereinafter referred to
China’s Confidentiality ...
Zunxia Li, Partner of IP MarchThe Supreme People’s Court of China (SPC) recently
Recently Published SPC J...
Zunxia Li, Partner of IP March BackgroundArticle 45 of the Patent Law of the PRC
The Pharmaceutical Paten...
Ms. Wei Yang, Partner, IP March The pharmaceutical industry is among the most he
Trademark Law Revision: ...
The newly revised Chinese Trademark Law has recently been promulgated and will t
CNIPA released newly rev...
In recent times, issues surrounding the cancellation of registered trademarks fo
Insights and Considerati...
Ruxolitinib, a selective JAK1/JAK2 inhibitor developed by Incyte Corporation, wo
Definition and Acceptabl...
Introduction“Disclaimer amendment” refers to a manner of claim amendment to excl
Protecting consumer inte...
In the examination and trial of trademarks, consumers as the key participants in
Exploration of Graphical...
——Strategies for forming a relatively independent area and constituting a relati